Coliseum Capital Partners, L.P.'s Form 4 filing
Accendra Health Inc (ACH) · filed Apr 7, 2025
- Accession no.
- 0000950170-25-051751
- Filed
- Apr 7, 2025, 8:21 PM ET
- Trade date
- Apr 3-7, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $4.29M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Coliseum Capital Partners, L.P.CIK 0001356974 | 10% Owner |
| Coliseum Capital, LLCCIK 0001409585 | 10% Owner |
| Coliseum Capital Management, LLCCIK 0001409751 | 10% Owner |
| Shackelton Christopher SCIK 0001430708 | 10% Owner |
| Gray AdamCIK 0001454123 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 3, 2025 | Common Stock, par value $2 per share ("Common Stock") | PPurchaseAcquired | +160,000 | $8.53 | +$1,364,800 | 10,784,599 | Indirect | |
| Apr 4, 2025 | Common Stock | PPurchaseAcquired | +128,356 | $8.14 | +$1,044,817.84 | 10,912,955 | Indirect | |
| Apr 7, 2025 | Common Stock | PPurchaseAcquired | +240,000 | $7.84 | +$1,881,600 | 11,152,955 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.